ORENCIA
ORENCIA
Approved
DIN Number
02282097
Drug Class
Human
Market Date
Aug 8, 2006
Company
HC
bristol-myers squibb canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02282097
AIG Number0151647001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AA24 ABATACEPT
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:24.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ABATACEPTActive
Strength: 250 MG / VIAL
Monograph: ABATACEPT